Cited by 686Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and LipoproteinsDialysis and Renal Disease Management

The DOI matches its Crossref record; 108 of the 111 references it cites were found in a registry or an index.

The Global Epidemiology of Diabetes and Kidney Disease

Open access

Koye, Digsu N., Magliano, Dianna J., Nelson, Robert G., Pavkov, Meda E.·2018·Advances in Chronic Kidney Disease

DOI 10.1053/j.ackd.2017.10.011PMC PMC11000253

Open this paper in CoChat — free account

Abstract

The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.ackd.2017.10.011

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S. M., Prosek, J. M., Nádasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,392
Chronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Type 1 diabetes
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Robinson, B. M., Abbott, K. C., Agodoa, L. Y. C., Albertus, P., Ayanian, J. Z., Balkrishnan, R., Bragg‐Gresham, J. L., Cao, J., Chen, J. L. T., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.12.004 · Cited by 2,192

Show all 111 references

Research works printed but not linked: 1

2018, 2017 USRDS Annual Data Report: Executive Summary. Chapter 2: Identification and Care of Patients With CKD, Am J Kidney Dis, 71, S31

Sorted by citations

Items 101–200 of 684

Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
El‐Remessy, A. B. (2022) · Endocrines · doi:10.3390/endocrines3040066 · Cited by 33
Identification of the main flavonoids of Abelmoschus manihot (L.) medik and their metabolites in the treatment of diabetic nephropathy
Diao, Z., Yu, H., Wu, Y., Sun, Y., Tang, H., Wang, M., Li, N., Ge, H., Sun, J., & Gu, H. F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1290868 · Cited by 27
Placenta-derived mesenchymal stem cells protect against diabetic kidney disease by upregulating autophagy-mediated SIRT1/FOXO1 pathway
Liu, H., Wang, J., Yue, G., & Xu, J. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2303396 · Cited by 27
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease
Piko, N., Bevc, S., Hojs, R., & Ekart, R. (2024) · Pharmaceuticals · doi:10.3390/ph17040418 · Cited by 32
Sarcopenic obesity is associated with a faster decline in renal function in people with type 2 diabetes
Fukuda, T., Bouchi, R., Asakawa, M., Takeuchi, T., Shiba, K., Tsujimoto, K., Komiya, C., Yoshimoto, T., Ogawa, Y., & Yamada, T. (2019) · Diabetic Medicine · doi:10.1111/dme.14153 · Cited by 26
Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement
Roy, A., Maiti, A., Sinha, A., Baidya, A., Basu, A. K., Sarkar, D., Sanyal, D., Biswas, D., Maisnam, I., Pandit, K., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00921-y · Cited by 27
Transforming the Care of Patients with Diabetic Kidney Disease
Brosius, F. C., Cherney, D. Z. I., Gee, P. O., Harris, R. C., Kliger, A. S., Tuttle, K. R., & Quaggin, S. E. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.18641120 · Cited by 28
MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies
Dhas, Y., Arshad, N., Biswas, N., Jones, L., & Ashili, S. (2023) · Biomedicines · doi:10.3390/biomedicines11092583 · Cited by 27
Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients
Ngan, D. T. T., Bình, N. G., Lan, L. T. H., Nguyen, C. T. T., & Huong, P. T. (2019) · Journal of Medical Biochemistry · doi:10.2478/jomb-2019-0037 · Cited by 27
O‐linked β‐N‐acetylglucosamine (O‐ GlcNAc ) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy
Qi, B., Chen, Y., Chai, S., Lü, X., & Kang, L. (2024) · Diabetic Medicine · doi:10.1111/dme.15436 · Cited by 30
Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis
Qin, Y., Zhang, S., Shen, X., Zhang, S., Wang, J., Zuo, M., Cui, X., Gao, Z., Yang, J., Zhu, H., et al. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819891110 · Cited by 28
Sex-Specific Computational Models of Kidney Function in Patients With Diabetes
Swapnasrita, S., Carlier, A., & Layton, A. T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.741121 · Cited by 26
The Predictive Ability of C-Peptide in Distinguishing Type 1 Diabetes From Type 2 Diabetes: A Systematic Review and Meta-Analysis
Iqbal, S., Jayyab, A. A., Alrashdi, A. M., & Reverté-Villarroya, S. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.01.004 · Cited by 27
Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease
Cliff, C. L., Squires, P. E., & Hills, C. E. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01728-1 · Cited by 25
High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
Perkins, B. A., Rabbani, N., Weston, A. J., Adaikalakoteswari, A., Lee, J. A., Lovblom, L. E., Cardinez, N., & Thornalley, P. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-69350-y · Cited by 25
Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
Balint, L., Socaciu, C., Socaciu, A. I., Vlad, A., Gădălean, F., Bob, F. R., Milas, L. O., Cretu, O. M., Suteanu‐Simulescu, A., Glavan, M., et al. (2023) · Biomolecules · doi:10.3390/biom13071086 · Cited by 28
Depression with Comorbid Diabetes: What Evidence Exists for Treatments Using Traditional Chinese Medicine and Natural Products?
Lu, Y., An, T., Tian, H., Gao, X., Wang, F., Wang, S., & Ma, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.596362 · Cited by 26
Retinal microvascular signs and risk of diabetic kidney disease in asian and white populations
Nusinovici, S., Sabanayagam, C., Lee, K. E., Zhang, L., Cheung, C. Y.-L., Tai, E. S., Tan, G. S. W., Cheng, C., Klein, B. E. K., & Wong, T. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-84464-7 · Cited by 24
Sex-Related Aspects in Diabetic Kidney Disease—An Update
Loeffler, I., & Ziller, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082834 · Cited by 24
The therapeutic effect of mesenchymal stem cells in diabetic kidney disease
Habiba, U. E., Khan, N., Greene, D. L., Shamim, S., & Umer, A. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-024-02432-w · Cited by 26
Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial
Waki, K., Nara, M., Enomoto, S., Mieno, M., Kanda, E., Sankoda, A., Kawai, Y., Miyake, K., Wakui, H., Tsurutani, Y., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01114-8 · Cited by 26
Urinary Extracellular Vesicles for Diabetic Kidney Disease Diagnosis
Saenz‐Pipaon, G., Andueza, S. E., Orbe, J., & Roncal, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102046 · Cited by 24
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease
Rhee, C. M., Kalantar‐Zadeh, K., & Tuttle, K. R. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000756 · Cited by 27
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care
Fadini, G. P., Longato, E., Morieri, M. L., Bonora, E., Consoli, A., Fattor, B., Rigato, M., Turchi, F., Prato, S. D., Avogaro, A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06251-z · Cited by 28
Machine learning-based risk predictive models for diabetic kidney disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis
Li, Y., Jin, N., Zhan, Q., Huang, Y., Sun, A., Yin, F., Li, Z., Hu, J., & Liu, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1495306 · Cited by 22
“While the diversity of data sources enriches the model ’ s input dimensions, it may also introduce issues related to data quality and consistency (5).”
Nephroprotective Effects of Tetramethylpyrazine Nitrone TBN in Diabetic Kidney Disease
Jing, M., Cen, Y., Gao, F., Wang, T., Jiang, J., Jian, Q., Wu, L., Guo, B., Luo, F., Zhang, G., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.680336 · Cited by 22
Nephroprotective Effect of the Virgin Olive Oil Polyphenol Hydroxytyrosol in Type 1-like Experimental Diabetes Mellitus: Relationships with Its Antioxidant Effect
Rodríguez-Pérez, M. D., López-Villodres, J. A., Arrebola, M. M., Aurioles, E. M., Fernández‐Prior, Á., Oria, A. B., Ríos, M. C., Cruz, J. P. D. L., & Correa, J. A. G. (2021) · Antioxidants · doi:10.3390/antiox10111783 · Cited by 24
Protecting the Kidneys: Update on Therapies to Treat Diabetic Nephropathy
Davis, K. N., Hines, A., Schaefer, M. C., & Naseman, K. (2022) · Clinical Diabetes · doi:10.2337/cd21-0090 · Cited by 22
Prevalence and risk factors of chronic kidney disease among patients with type 2 diabetes mellitus at a tertiary care hospital in Nepal: a cross-sectional study
Joshi, R., Subedi, P., Yadav, G. K., Khadka, S., Rijal, T., Amgain, K., & Rajbhandari, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067238 · Cited by 25
Comparative safety of sodium-glucose co-transporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis
Liu, Y., An, C., Liu, P., Yang, F., & Zhao, Q. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2217287 · Cited by 22
Analysis of the global burden of CKD-T2DM in young and middle-aged adults in 204 countries and territories from 2000 to 2019: A systematic study of the global burden of disease in 2019
Liu, B., Li, L., Cui, H., Zhao, Q., & Chen, S. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111884 · Cited by 26
Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications
Zhang, F., Shan, S., Fu, C.-L., Guo, S., Liu, C., & Wang, S. (2024) · Molecules · doi:10.3390/molecules29112530 · Cited by 22
Astragaloside IV protects renal tubular epithelial cells against oxidative stress‐induced injury by upregulating CPT1A‐mediated HSD17B10 lysine succinylation in diabetic kidney disease
Wang, M., Li, Q., Wang, S., Zuo, L., Hai, Y., Yuan, S., Li, X., Huang, X., Yang, C., Yao, L., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8298 · Cited by 23
Next-generation therapeutics for diabetic kidney disease
Yi, T. W., Sridhar, V. S., Scott, J., Nardone, M., & Cherney, D. Z. I. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01042-0 · Cited by 24
Glycosylation of IgG Associates with Hypertension and Type 2 Diabetes Mellitus Comorbidity in the Chinese Muslim Ethnic Minorities and the Han Chinese
Meng, X., Song, M., Vilaj, M. Ć., Štambuk, J., Mamatyusupu, D., Zhang, J., Liu, D., Wang, H., Zhang, X., Zhang, J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070614 · Cited by 21
Longitudinal Associations Between Vision Impairment and the Incidence of Neuropsychiatric, Musculoskeletal, and Cardiometabolic Chronic Diseases
Kolli, A., Seiler, K., Kamdar, N. S., Lott, L. B. D., Peterson, M. D., Meade, M. A., & Ehrlich, J. R. (2021) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2021.09.004 · Cited by 21
Klotho in kidney diseases: a crosstalk between the renin–angiotensin system and endoplasmic reticulum stress
Kale, A., Sankrityayan, H., Anders, H., & Gaikwad, A. B. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab340 · Cited by 21
Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches
Narongkiatikhun, P., Chattipakorn, S. C., & Chattipakorn, N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17116 · Cited by 21
A Non-Immunized and BSA-Template Aggregation-Induced Emission Sensor for Noninvasive Detection of Cystatin C in the Clinical Diagnosis of Diabetes Nephropathy
Chen, S., Du, K., Wang, S., Liang, C., Shang, Y., Xie, X., Tang, G., Li, J., Wang, B., Yu, X., et al. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02122 · Cited by 21
The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes
Kearney, J., & Gnudi, L. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051343 · Cited by 22
The burden of cardiovascular diseases attributable to metabolic risk factors and its change from 1990 to 2019: a systematic analysis and prediction
Wang, H., Liu, J., Feng, Y., Ma, A., & Wang, T. (2023) · Frontiers in Epidemiology · doi:10.3389/fepid.2023.1048515 · Cited by 21
Improving Prediction of Chronic Kidney Disease Using KNN Imputed SMOTE Features and TrioNet Model
Alturki, N. M., Altamimi, A., Umer, M., Saidani, O., Alshardan, A., Alsubai, S., Omar, M., & Ashraf, I. (2024) · Computer Modeling in Engineering & Sciences · doi:10.32604/cmes.2023.045868 · Cited by 21
Diabetes Mellitus and Pneumococcal Pneumonia
Cillóniz, C., & Torres, A. (2024) · Diagnostics · doi:10.3390/diagnostics14080859 · Cited by 21
Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials
Zhou, Y., Chi, J., Huang, Y., Dong, B., Lv, W., & Wang, Y. (2020) · Diabetic Medicine · doi:10.1111/dme.14411 · Cited by 20
Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey
Cappetta, D., Angelis, A. D., Bellocchio, G., Telesca, M., Cianflone, E., Torella, D., Rossi, F., Urbanek, K., & Berrino, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.810791 · Cited by 21
The clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus
Xu, H., Chen, R., Hou, X., Li, N., Han, Y., & Ji, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1471577 · Cited by 20
Associations of Cardiovascular-Kidney-Metabolic Syndrome with Premature Mortality and Life Expectancies in US Adults: A Cohort Study
Lei, L., Li, J., Ding, W., Wang, W., Yu, Y., Pu, B., Peng, Y., Zhang, L., & Guo, Y. (2025) · Cardiorenal Medicine · doi:10.1159/000546618 · Cited by 24
The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies
Zoppini, G., Bergamini, C., Mantovani, A., Dauriz, M., Targher, G., Rossi, A., & Bonora, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209794 · Cited by 20
Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease
Kourtidou, C., Stangou, M. J., Marinaki, S., & Τζιόμαλος, Κ. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011196 · Cited by 20
The effect of renin–angiotensin–aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials
Alsalemi, N., Sadowski, C. A., Elftouh, N., Louis, M., Kilpatrick, K., Houle, S. K. D., & Lafrance, J. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02763-1 · Cited by 21
Prevalence of diabetic nephropathy in the diabetes mellitus population: A protocol for systematic review and meta-analysis
Li, S., Xie, H., Shi, Y., & Liu, H. (2022) · Medicine · doi:10.1097/md.0000000000031232 · Cited by 20
GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity
Cooper, M. E., & van Raalte, D. H. (2025) · Journal of Clinical Investigation · doi:10.1172/jci194749 · Cited by 24
The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database
Anson, M., Henney, A. E., Edwards, H., Ibarburu, G. H., Mordi, I. R., Jaffar, S. S., Garrib, A. V., Lip, G. Y. H., Wang, D., Nabrdalik, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112431 · Cited by 23
Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes
Jiang, G., Luk, A. O. Y., Tam, C. H. T., Ozaki, R., Lim, C. K. P., Chow, E., Lau, E. S. H., Kong, A. P. S., Fan, B., Hong Kong Diabetes Register TRS Study Group, et al. (2022) · Diabetes · doi:10.2337/db21-0694 · Cited by 19
Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis
Wei, R., Qiao, J., Cui, D., Pan, Q., & Guo, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.883658 · Cited by 20
Research progress of gut microbiome and diabetic nephropathy
Chu, C., Behera, T. R., Huang, Y., Qiu, W., Chen, J., & Shen, Q. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1490314 · Cited by 19
Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes
Korbut, A. I., Klimontov, V. V., Vinogradov, I. V., & Romanov, V. V. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i11.517 · Cited by 20
Glycosylation in kidney diseases
Ling, Y., Cai, F., Su, T., Zhong, Y., Li, L., Meng, B., Li, G., Gong, M., Yang, H., Xie, X., et al. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf017 · Cited by 19
Prevalence of Diabetes Mellitus and Its Associated Unfavorable Outcomes in Patients With Acute Respiratory Syndromes Due to Coronaviruses Infection: A Systematic Review and Meta-Analysis
Pinedo-Torres, I. A., Flores-Fernández, M., Yovera-Aldana, M., Gutiérrez‐Ortiz, C., Zegarra-Lizana, P. A., Intimayta‐Escalante, C., Morán‐Mariños, C., Alva‐Díaz, C., & Pacheco‐Barrios, K. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420962495 · Cited by 19
Isolation of Chalcomoracin as a Potential α-Glycosidase Inhibitor from Mulberry Leaves and Its Binding Mechanism
Liu, Y., Zhou, X., Zhou, D., Jian, Y., Jia, J., & Ge, F. (2022) · Molecules · doi:10.3390/molecules27185742 · Cited by 18
Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications
Plowman, T. J., Shah, M. H., Fernandez, E., Christensen, H., Aiges, M., & Ramana, K. V. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666220922114701 · Cited by 19
Noninvasive Assessment of Diabetic Kidney Disease With MRI : Hype or Hope?
Zhao, K., Seeliger, E., Niendorf, T., & Liu, Z. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29000 · Cited by 18
Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: Possible involvement of O-GlcNAcylation
da Costa, R. M., Dias, M. C., Alves, J. V., Silva, J. L. M., Rodrigues, D., da Silva, J. F., Francescato, H. D. C., Ramalho, L. N. Z., Coimbra, T. M., & Tostes, R. C. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115982 · Cited by 19
Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 Diabetes
Tu, Z., Du, J., Ge, X., Peng, W., Shen, L., Xia, L., Jiang, X., Hu, F., & Huang, S. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01609-3 · Cited by 20
Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice
Weng, W., Ge, T., Wang, Y., He, L., Liu, T., Wang, W., Zheng, Z., Yu, L., Zhang, C., & Lu, X. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0089 · Cited by 18
The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics
Migdalis, I. N., Παπάνας, Ν., Raptis, A. E., Ioannidis, I., Sotiropoulos, A., & Dimitriadis, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108243 · Cited by 18
Systematic Review of Cardiovascular Outcome Trials Using New Antidiabetic Agents in CKD Stratified by Estimated GFR
Arshad, A., Sarween, N., & Sharif, A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.06.029 · Cited by 19
LRH ‐1 activation alleviates diabetes‐induced podocyte injury by promoting GLS2 ‐mediated glutaminolysis
Hu, J., Zhang, Z., Hu, H., Yang, K., Zhu, Z., Yang, Q., & Liang, W. (2023) · Cell Proliferation · doi:10.1111/cpr.13479 · Cited by 17
Fumaria parviflora improves liver damage and lipid profile changes in STZ-induced diabetic rats
Kooshki, F., Niazkar, H. R., Shirazi, S., Azar, V. A., & Karimi, A. (2020) · Physiology and Pharmacology · doi:10.32598/ppj.24.3.80 · Cited by 18
The role of endothelin receptor antagonists in kidney disease
Ma, X., Liang, Y., Chen, W., Zheng, L., Lin, H., & Zhou, T. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2465810 · Cited by 17
‘Oxidative stress’-A new target in the management of diabetes mellitus
Das, A. K., Kalra, S., Punyani, H., Deshmukh, S. N., & Taur, S. R. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2249_21 · Cited by 16
Fucoidan MF4 from Fucus vesiculosus inhibits Lewis lung cancer via STING–TBK1–IRF3 pathway
Shi, C., Zhao, S., Mi, L., Niu, D., Hu, F., Han, W., & Li, B. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131336 · Cited by 16
Global, regional, and national burden of chronic kidney disease due to diabetes mellitus type 2 from 1990 to 2021, with projections to 2036: a systematic analysis for the Global Burden of Disease Study 2021
Hu, R., Zhao, Z., Xie, L., Ma, Z., Wu, W., & Li, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1531811 · Cited by 21
Association of diabetes mellitus with hepatitis B and hepatitis C virus infection: evidence from an epidemiological study
Liu, Y., Ye, S., Xiao, X., Zhou, T., Yang, S., Wang, G., Sun, C., Zhang, B., & Wang, G. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s218536 · Cited by 16
Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease
Diao, M., Wu, Y., Yang, J., Liu, C., Xu, J., Jin, H., Wang, J., Zhang, J., Gao, F., Jin, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.843721 · Cited by 16
IL-17A in diabetic kidney disease: protection or damage
Tan, H., Zheng, Y., & Zhuang, Y.-P. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108707 · Cited by 15
ER Stress-Perturbed Intracellular Protein O-GlcNAcylation Aggravates Podocyte Injury in Diabetes Nephropathy
Song, S., Hu, T., Shi, X. D., Jin, Y., Liu, S., Li, X., Zou, W., & Wang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417603 · Cited by 15
Analysis of chronic kidney disease epidemiology in Kazakhstan using nationwide data for 2014–2020 and forecasting future trends of prevalence and mortality for 2030
Zhakhina, G., Mussina, K., Yerdessov, S., Gusmanov, A., Sakko, Y., Kim, V., Syssoyev, D., Madikenova, M., Assan, A., Kuanshaliyeva, Z., et al. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2326312 · Cited by 15
Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning
Yun, C., Tang, F., Gao, Z., Wang, W., Bai, F., Miller, J. D., Liu, H., Lee, Y., & Lou, Q. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0033 · Cited by 19
Pathogenic role of PFKFB3 in endothelial inflammatory diseases
Zhou, L., Li, J., Wang, J., Niu, X., Li, J., & Zhang, K. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1454456 · Cited by 15
Causes, comorbidities and current status of chronic kidney disease
Jacob, S. R., Raveendran, R., & Kannan, S. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_478_19 · Cited by 15
Connexin‐mediated cell communication in the kidney: A potential therapeutic target for future intervention of diabetic kidney disease?
Price, G. W., Potter, J. A., Williams, B. M., Cliff, C. L., Squires, P. E., & Hills, C. E. (2019) · Experimental Physiology · doi:10.1113/ep087770 · Cited by 15
Burden of diabetes and kidney disease attributable to non-optimal temperature from 1990 to 2019: A systematic analysis from the Global Burden of Disease Study 2019
Liu, Y., Wen, H., Bai, J., Shi, F., Bi, R., & Yu, C. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156495 · Cited by 14
Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice
Zhu, Q., Zhou, Q., Luo, X.-L., Zhang, X., & Li, S.-Y. (2023) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2023.27.3.221 · Cited by 14
Traditional Chinese medicine for the treatment of immune-related nephropathy: A review
Pu, J., Yao, C., & Guo, D. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.006 · Cited by 14
The Association between Dapagliflozin Use and the Risk of Post-Contrast Acute Kidney Injury in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity-Matched Analysis
Liu, T., Jian, X., Li, L., Chu, S., & Fan, Z. (2023) · Kidney & Blood Pressure Research · doi:10.1159/000535208 · Cited by 15
Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center
Durma, A. D., Saracyn, M., Kołodziej, M., Jóźwik−Plebanek, K., Dmochowska, B., Kapusta, W., Żmudzki, W., Mróz, A., Kos‐Kudła, B., & Kamiński, G. (2023) · Cancers · doi:10.3390/cancers15225466 · Cited by 14
Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
Kruger, D. F., & Valentine, V. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00826-w · Cited by 14
The Efficacy of Triptolide in Preventing Diabetic Kidney Diseases: A Systematic Review and Meta-Analysis
Liang, D., Mai, H., Ruan, F., & Fu, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.728758 · Cited by 14
Identification of Diabetes through Urine Using Gas Sensor and Convolutional Neural Network
(2021) · International journal of intelligent engineering and systems · doi:10.22266/ijies2022.0228.47 · Cited by 14
The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses
Zhao, Y., Yan, G., Mi, J., Wang, G., Yu, M., Jin, D., Tong, X., & Wang, X. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/8400106 · Cited by 14
Retracted
Effect of exercise-based rehabilitation on functional capacity and renal function in type 2 diabetes mellitus with nephropathy: a randomized controlled trial
Nataraj, M., Maiya, A. G., Nagaraju, S. P., Shastry, B. A., Shivashankara, K. N., Shetty, S., & Mayya, S. S. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-03987-w · Cited by 14
Curcumin/piperine modulates the butyrate levels and alleviates diabetic kidney disease via Nrf2/HO-1 signaling pathway
Zhu, Y., Sun, L., Guo, Z., Xin, P., Huang, F., Song, L., Man, Y., Ren, M., Ma, Z., & Wang, Y. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2538117 · Cited by 13
High-Throughput Screening of Natural Products Alleviating Diabetic Nephropathy Using a Peroxynitrite (ONOO – ) Responsive Fluorescent Probe
Chen, B., Liu, J., Liu, X., Zhang, J., Zhong, Y., Wang, W., & Zhou, J. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03228 · Cited by 13
Risk of Tuberculosis Disease in People With Chronic Kidney Disease Without Kidney Failure: A Systematic Review and Meta-analysis
Luczynski, P., Holmes, T. W., Romanowski, K., Arbiv, O. A., Cook, V. J., Clark, E. G., & Johnston, J. C. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad364 · Cited by 15
Clinical Use and Treatment Mechanism of Molecular Hydrogen in the Treatment of Various Kidney Diseases including Diabetic Kidney Disease
Hirano, S., Ichikawa, Y., Sato, B., Takefuji, Y., & Satoh, F. (2023) · Biomedicines · doi:10.3390/biomedicines11102817 · Cited by 12
Hybrid machine learning model to predict chronic kidney diseases using handcrafted features for early health rehabilitation
Rehman, A. U., Saba, T., Ali, H., ElHakim, N., & Ayesha, N. (2023) · TURKISH JOURNAL OF ELECTRICAL ENGINEERING & COMPUTER SCIENCES · doi:10.55730/1300-0632.4028 · Cited by 13
Ingested nitrate and nitrite and end-stage renal disease in licensed pesticide applicators and spouses in the Agricultural Health Study
Chen, D., Parks, C. G., Freeman, L. E. B., Hofmann, J. N., Sinha, R. R., Madrigal, J. M., Ward, M. H., & Sandler, D. P. (2024) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-023-00625-y · Cited by 17
Prevalence of diabetic kidney disease and the associated factors among patients with type 2 diabetes in a multi-ethnic Asian country
Wan, K. S., Hairi, N. N., Mustapha, F. I., Yusoff, M. F. M., Rifin, H. M., Ismail, M., Moy, F. M., & Ahmad, N. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-57723-6 · Cited by 13
Network pharmacology and molecular dynamics study of the effect of the Astragalus-Coptis drug pair on diabetic kidney disease
Zhang, M., & Zheng, S. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1562 · Cited by 13

Authors: Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E.
Affiliations: Centers for Disease Control and Prevention (US)
Corresponding author: Pavkov, Meda E.
ORCID: Koye, Digsu N.
Magliano, Dianna J.
Nelson, Robert G.
Pavkov, Meda E.
Venue: Advances in Chronic Kidney Disease
Publisher: Elsevier BV
Published: 2018-03
Volume: 25
Issue: 2
Pages: 121-132
ISSN: 1548-5595 (ISSN-L)
DOI: 10.1053/j.ackd.2017.10.011
PMC: PMC11000253
OpenAlex: W2790284551
Cited by: 686
References: 111
Citations by year: 2026: 79 · 2025: 111 · 2024: 137 · 2023: 109 · 2022: 101 · 2021: 78 · 2020: 44 · 2019: 19 · 2018: 7
FWCI: 6.35
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Advances in Chronic Kidney Disease (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (CC999999)
Topics: Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords: diabetes mellitus, chronic kidney disease, type 2 diabetes, end-stage renal disease, diabetes prevalence, diabetes incidence, diabetes mortality, cardiovascular disease, low- and middle-income countries, disease awareness
MeSH terms: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Humans, Global Health, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Global Epidemiology of Diabetes and Kidney Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks